Skip to main content
HimalayasHimalayas logo
Alentis TherapeuticsAT

Alentis Therapeutics

Alentis Therapeutics is a clinical-stage biotech company developing first-in-class anti-Claudin-1 antibodies and ADCs for cancer and fibrosis. Its pipeline includes oncology candidates such as ALE.P02/ALE.P03 and the fibrosis program Lixudebart (ALE.F02).

About Alentis Therapeutics

Alentis Therapeutics is a clinical-stage biotech company focused on treating cancer and reversing fibrosis by targeting Claudin-1 (CLDN1). Across its pipeline, the team advances anti-Claudin-1 monoclonal antibodies and antibody-drug conjugates (ADCs) designed to specifically bind exposed CLDN1 in tumors and fibrotic tissue. The company’s mission is to unlock the broad therapeutic potential of Claudin-1 - an important target that is overexpressed and exposed outside tight junctions in both fibrosis and many cancers.

At the core of Alentis’ approach is a translation-focused Claudin-1 program built from founder-led research. The company describes its leadership team and broader organization as values-driven, emphasizing collaboration, hard work, and a shared belief that anti-Claudin-1 therapies can make a meaningful difference for patients. Alentis’ clinical development includes ADC candidates such as ALE.P02 and ALE.P03 for CLDN1+ oncology indications, and the fibrosis program through Lixudebart (formerly ALE.F02), aiming to preserve or restore organ function by addressing fibrotic signaling and the collagen barrier.

FAQs

When was Alentis Therapeutics founded?
Alentis Therapeutics was founded in 2019.
Who is the CEO of Alentis Therapeutics?
Mark Pruzanski is the CEO.
What industries or markets does Alentis Therapeutics operate in?
Alentis Therapeutics operates in the following markets: Biotechnology, Clinical Stage Drug Development, Oncology Therapeutics, Fibrosis Therapeutics, Monoclonal Antibody Therapeutics, Antibody Drug Conjugates (ADCs), Targeted Cancer Therapies, Translational Medicine, Precision Medicine Biomarker Driven Therapeutics, and Pharmaceutical.
How many employees does Alentis Therapeutics have?
Alentis Therapeutics has 51-200 employees.
Where does Alentis Therapeutics have employees?
Alentis Therapeutics has employees in Switzerland.
Does Alentis Therapeutics support remote work or working from home?
Yes, Alentis Therapeutics is a remote-friendly company.
Does Alentis Therapeutics offer a four-day work week?
No, Alentis Therapeutics does not offer a four-day work week.
What is Alentis Therapeutics's website?
Alentis Therapeutics's website is alentis.ch.
Where can I find Alentis Therapeutics on social media?
You can find Alentis Therapeutics on LinkedIn.

Remote companies like Alentis Therapeutics

Find your next opportunity by exploring profiles of companies that are similar to Alentis Therapeutics. Compare culture, benefits, and job openings on Himalayas.

View all companies

Find your dream job

Sign up now and join over 250,000+ remote workers who receive personalized job alerts, curated job matches, and more for free!

Sign up
Himalayas profile for an example user named Frankie Sullivan
Alentis Therapeutics | Himalayas